Location History:
- St. Louis, MO (US) (1989 - 2005)
- Irvine, CA (US) (2018)
Company Filing History:
9 out of 469 
3 out of 1,586 
2 out of 1,173 
Years Active: 1989-2018
Title: **David W. Scharp: Innovator in Biocompatible Solutions**
Introduction
David W. Scharp is a prolific inventor based in St. Louis, MO, whose innovative work has led to the acquisition of 14 patents. His research focuses on advancing biomedical technologies, particularly in the areas of cell coating and the development of immunoisolatory vehicles for therapeutic applications.
Latest Patents
Two of Scharp's latest patents underscore his commitment to enhancing therapeutic methodologies:
1. **Coating for Cells, Reagents, and Methods** - This patent details the process of coating mammalian cells, providing related reagents and methods for both the coating and subsequent implantation of these cells into a human host.
2. **Implantable Biocompatible Immunoisolatory Vehicle for Delivery of Selected Therapeutic Products** - This innovative device is designed for implantation into individuals, focusing on the delivery of therapeutic products through a core region that maintains isolated cells while providing the necessary biocompatibility. This vehicle is particularly effective in insulin delivery from immunoisolated islets of Langerhans and can accommodate high molecular weight products. The patent also includes methods for the vehicle's construction and the isolation of cells within it.
Career Highlights
Scharp has had a notable career, significantly contributing to the fields he specializes in. He has worked for prestigious institutions, including Brown University Research Foundation and Washington University, where his research initiatives have paved the way for crucial advancements in biomedical technologies.
Collaborations
Throughout his career, Scharp has collaborated with esteemed colleagues, such as Paul E. Lacy and Keith E. Dionne. These partnerships have further enriched his research and contributions to the field of biocompatible implants and therapies.
Conclusion
David W. Scharp's innovative spirit and dedication to advancing medical technology are evident through his numerous patents and research collaborations. His work not only contributes to the scientific community but also holds the potential to improve patient outcomes through enhanced therapeutic methods. As he continues to explore the possibilities within biocompatible systems, Scharp's contributions will likely remain influential in the realm of biomedical innovations.